The iShares ESG Aware MSCI USA Small-Cap ETF (ESML) has an implied analyst target price of $49.84 per unit, indicating a potential upside of 19.16% from its recent trading price of $41.83. This analysis is based on the underlying holdings of the ETF.
Notably, three of ESML’s holdings show significant upside potential: IDEAYA Biosciences Inc (IDYA) has a recent price of $22.84 with a target of $46.21, suggesting a 102.34% upside; Klaviyo Inc (KVYO) trades at $30.07, with a target price of $44.80 (48.99% upside); and CRISPR Therapeutics AG (CRSP) is priced at $55.41, with a target of $80.74 (45.71% upside).
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| iShares ESG Aware MSCI USA Small-Cap ETF | ESML | $41.83 | $49.84 | 19.16% |
| IDEAYA Biosciences Inc | IDYA | $22.84 | $46.21 | 102.34% |
| Klaviyo Inc | KVYO | $30.07 | $44.80 | 48.99% |
| CRISPR Therapeutics AG | CRSP | $55.41 | $80.74 | 45.71% |
